GZIRA, Malta, July 1, 2026 /PRNewswire/ -- SOFTSWISS has introduced new positioning and a refreshed visual identity in response to structural changes reshaping iGaming markets today. Insights from five years of SOFTSWISS iGaming Trends research show that operators increasingly expect technology providers to deliver more than software.

  • Updated

Amid the rapidly evolving Ebola virus disease (EVD) outbreak involving the rare Bundibugyo ebolavirus sub-type, for which there are no approved medications or vaccines, RedHill Biopharma is actively discussing potential collaborations for clinical advancement of opaganib1, including the World Health Organization's (WHO) SOLIDARITY CORE clinical trial platform